FrankXavierVenzaraIIIMD

Ophthalmology • Merritt Island, FL

Retinal Disease

Owner, Florida Retina Specialists

Join to view full profile

Dr. Venzara is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Venzara's full profile

Already have an account?

Office
280 N Sykes Creek Pkwy
Suite B
Merritt Island, FL 32953
Phone+1 321-735-8800

Fax+1 321-735-8898
Is this information wrong?

Education & Training

Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Ophthalmology, 2009 - 2012
Texas A&M College of Medicine-Scott and White Medical Center (Temple)Internship, Internal Medicine, 2008 - 2009
University of Miami Leonard M. Miller School of MedicineClass of 2008
University of MiamiB.S., Biomedical Engineering; Minor: Chemistry, 1999 - 2003

Awards, Honors, & Recognition

Edward W.D. Norton Memorial Award For Excellence in Research and Clinical Ophthalmology, Department of Ophthalmology Bascom Palmer Eye Institute, 2008
Recipient of Fight for Sight Student Fellowship Research Grant 2006
Recipient of Research Grant University of Miami Center for Aging, 2003
Provost Honor Roll University of Miami
Tau Beta Pi Engineering Honor Society
Join now to see all

Publications & Presentations

Journal Articles

Reversible dysfunction of retinal ganglion cells in non-secreting pituitary tumors
Ventura LM, Venzara FX, Porciatti V, Doc Ophthalmol, 1/1/2009

Abstracts/Posters

Rate and Risk of Ocular Neovascularization in Eyes With a Central Retinal Artery Occlusion
Mason J, Venzara FX, Agee S. et al, American Academy of Ophthalmology, Chicago, IL, 1/1/2014
Safety and efficacy of 25-gauge Sutureless Vitrectomy for Idiopathic Macular Pucker
Mason J, Venzara FX, Agee S. et al, American Academy of Ophthalmology, Chicago, IL, 1/1/2014
Comparison of outcomes after switching treatment from intravitreal bevacizumab or ranibizumab to aflibercept in neovascular age-related macular degeneration.
Venzara FX, Glover J, Mason J. et al, Association For Research in Vision and Ophthalmology, Seattle, WA, 1/1/2013
Evaluation of Anti-VEGF Therapy in Peripapillary Chroidal Neovascular Membrances
Arceneaux R, Venzara FX, Mason J, University of Alabama Clinical Research Symposium, Birmingham, AL, 1/1/2013
Functional and anatomical effects of intravitreal bevacizumab and ranibizumab for neovascular ARMD, comparing two clinical protocols.
Venzara FX, Rosa R, Dieckert P, Texas A&M Scott & White Eye Institute Research Symposium, Temple, TX, 1/1/2013
Head-Down Posture Induces PERG Alterations in Glaucoma Suspects
Ventura LM, Golubev I, Venzara FX, et. al, Association For Research in Vision and Ophthalmology, Fort Lauderdale, FL, 1/1/2008
Reversible Dysfunction of Retinal Ganglion Cells in Compressive and Non-Compressive Pituitary Tumors
Venzara FX, Ventura LM, Porciatti V, Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 1/1/2007
Rates of Visual Field and PERG Changes Over 4 Years in Early Glaucoma
Ventura LM, Venzara FX, Porciatti V, Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 1/1/2007
Postural Changes of Intraocular Pressure and Their Impact on Retinal Ganglion Cell Function
Lima BD, Venzara FX, De Los Santos R, et. al, Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL, 1/1/2007
Tolerance of Retinal Ganglion Cell Function to Non Invasive Intraocular Pressure Test.
Venzara FX, Porciatt V, Ventura LM, University of Miami Eastern-Atlantic Student Research Forum, Miami, FL, 1/1/2007
Join now to see all

Hospital Affiliations

Health First Cape Canaveral HospitalCocoa Beach, Florida